BlackRock Fund Advisors’s Sinovac Biotech, Ltd SVA Stock Holding History

BlackRock Fund Advisors’s Portfolio SVA Stock Details SVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-802,736	Closed	-$4.08M	–	4412
2015 Q3	$4.08M	Buy	802,736 +74,170	+10%	+$393K	﹤0.01%	2906
2015 Q2	$3.83M	Buy	728,566 +24,093	+3%	+$127K	﹤0.01%	3035
2015 Q1	$3.49M	Buy	704,473 +42,738	+6%	+$211K	﹤0.01%	2997
2014 Q4	$3.46M	Sell	661,735 -17,878	-3%	-$91.2K	﹤0.01%	3037
2014 Q3	$3.27M	Buy	679,613 +21,132	+3%	+$113K	﹤0.01%	2988
2014 Q2	$3.71M	Sell	658,481 -18,698	-3%	-$114K	﹤0.01%	2993
2014 Q1	$4.88M	Buy	677,179 +43,815	+7%	+$290K	﹤0.01%	2832
2013 Q4	$3.88M	Buy	633,364 +32,836	+5%	+$198K	﹤0.01%	2960
2013 Q3	$3.59M	Buy	600,528 +91,601	+18%	+$438K	﹤0.01%	2994
2013 Q2	$2M	Buy	+508,927	New	+$1.89M	﹤0.01%	3099

Other funds holding SVA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

USAA

United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BlackRock Fund Advisors's SVA Position: Q4 2015 in Review

BlackRock Fund Advisors sold out of Sinovac Biotech, Ltd (SVA) in Q4 2015, closing a stake of 802,736 shares — an estimated $4.08M sold.

BlackRock Fund Advisors first reported a position in SVA in Q2 2013 and held it in 10 quarters. The position peaked at $4.88M in Q1 2014. 40 funds tracked by Wall St. Rank hold SVA as of Q4 2015.

BlackRock Fund Advisors reported no remaining Sinovac Biotech, Ltd position as of Q4 2015 after selling out during the quarter.
BlackRock Fund Advisors sold 802,736 Sinovac Biotech, Ltd shares in Q4 2015, an estimated $4.08M.
BlackRock Fund Advisors first reported a position in Sinovac Biotech, Ltd in Q2 2013 and held it in 10 quarters.
BlackRock Fund Advisors's Sinovac Biotech, Ltd position peaked at $4.88M in Q1 2014.
40 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q4 2015.

Based on BlackRock Fund Advisors's 13F filing for Q4 2015, filed 11 Feb 2016.